| Evidence for schizophrenia susceptibility alleles in the Indian population: an association of neurodevelopmental genes in case–control and familial samples A Jajodia, H Kaur, K Kumari, M Gupta, R Baghel, A Srivastava, M Sood, ... Schizophrenia research 162 (1-3), 112-117, 2015 | 35 | 2015 |
| Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy C Rawat, R Kutum, S Kukal, A Srivastava, UR Dahiya, S Kushwaha, ... Scientific reports 10 (1), 2546, 2020 | 30 | 2020 |
| Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective P Talwar, N Kanojia, S Mahendru, R Baghel, S Grover, G Arora, ... The pharmacogenomics journal 17 (3), 242-251, 2017 | 23 | 2017 |
| Systems approach to identify common genes and pathways associated with response to selective serotonin reuptake inhibitors and major depression risk A Srivastava, P Singh, H Gupta, H Kaur, N Kanojia, D Guin, M Sood, ... International journal of molecular sciences 20 (8), 1993, 2019 | 21 | 2019 |
| Evaluating the Role of Genetic Variants on first‐line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin … R Baghel, S Grover, H Kaur, A Jajodia, C Rawat, A Srivastava, ... CNS neuroscience & therapeutics 22 (9), 740-757, 2016 | 14 | 2016 |
| Synergistic association of STX1A and VAMP2 with cryptogenic epilepsy in North Indian population R Baghel, S Grover, H Kaur, A Jajodia, S Parween, J Sinha, A Srivastava, ... Brain and behavior 6 (7), 2016 | 11 | 2016 |
| Validating a genomic convergence and network analysis approach using association analysis of identified candidate genes in alzheimer’s disease P Talwar, S Kushwaha, C Rawat, H Kaur, A Srivastava, R Agarwal, ... Frontiers in Genetics 12, 722221, 2021 | 6 | 2021 |
| Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers P Singh, A Srivastava, D Guin, S Thakran, J Yadav, P Chandna, M Sood, ... International Journal of Neuropsychopharmacology 26 (10), 692-738, 2023 | 2 | 2023 |
| Pharmacotherapy for SARS-CoV-2 and Seizures for Drug Repurposing Presumed on Mechanistic Targets D Goel, A Srivastava, Á Aledo-Serrano, A Krishnan, D Vohora Current Molecular Pharmacology 15 (6), 832-845, 2022 | 1 | 2022 |
| Pharmacogenomics: an evolution towards clinical practice A Srivastava, D Guin, R Kukreti, D Vohora Pharmaceutical Medicine and Translational Clinical Research, 107-127, 2018 | 1 | 2018 |
| Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy R Chitra, K Rintu, K Samiksha, S Ankit, UR Dahiya, K Suman, S Sharma, ... Scientific Reports (Nature Publisher Group) 10 (1), 2020 | | 2020 |
| Schizophrenia susceptibility and neuregulin signaling pathway genes: A rare haplotype combination based association study in Indian population A Jajodia, H Kaur, A Srivastava, K Kumari, R Baghel, D Guin, M Sood, ... Psychiatry research 262, 628-630, 2018 | | 2018 |
